20th Mar 2023 13:06
Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about GBP1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes GBP500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, GBP5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing.
Current stock price: 4.13 pence, down 2.9% in London on Monday afternoon
12 month change: down 82%
By Sophie Rose, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
AVO.L